In view of the tendency toward vascular disease in diabetes mellitus, we studied platelet aggregation in 15 normal, 7 prediabetic, 12 latent, and 20 frankly diabetic subjects. Platelets from latent and frank diabetics showed increased platelet aggregation 4 minutes after adding adenosine 5'-diphosphate ( 6 0 % versus 2 9 % at 1.0 /zM), epinephrine (46 % versus 14 % at 0.25 ^M), and collagen ( 7 2 % versus 1 7 % at 0.25 ^g/ml). Three prediabetics had increased platelet aggregation. Platelet sensitivity to aggregating agents was most marked in frank diabetics, intermediate in latent diabetics, and least in prediabetics. Second-phase platelet aggregation was reversed with acetylsalicylic acid, intravenous tolbutamide, and oral glucose adm...
Patients with diabetes mellitus have an increased prevalence of vascular disease. Pathologic thrombo...
Hyperglycaemia may attenuate the antiplatelet effect of aspirin and thereby increase the risk of car...
Background. Disorders of hemostasis in patients with arterial hypertension and diabetes mellitus typ...
<p>Platelet aggregation in patients with coronary artery disease; 307 patients without diabetes (HbA...
The cause of retinopathy in diabetes mellitus is unknown. Among factors suggested to be involved in ...
Aims. To assess differences in blood formed elements aggregation activity in patients with type 1 ...
Patients with diabetes mellitus have an increased risk of thrombosis and accelerated atherogenesis. ...
Vascular complications in the course of type 11 diabetes mellitus are the most important causes of m...
frequently the final event in coronary or cerebral arterial occlusion, is a result of the interplay ...
Objective: The purpose of this study was to assess platelet aggregation (PA) in the diabetic and in ...
This study investigates whether experimental diabetes alters the ease with which platelet aggregatio...
WOS: 000174768500006PubMed ID: 11917198Background In noninsulin-dependent type II diabetic (tIIDM) p...
Contrasting data have been reported so far on the role of reticulated platelets in suboptimal respon...
Hyperglycaemia may attenuate the antiplatelet effect of aspirin and thereby increase the risk of car...
Having previously shown an increase in white blood cell (WBC) aggregation in groups known to have a ...
Patients with diabetes mellitus have an increased prevalence of vascular disease. Pathologic thrombo...
Hyperglycaemia may attenuate the antiplatelet effect of aspirin and thereby increase the risk of car...
Background. Disorders of hemostasis in patients with arterial hypertension and diabetes mellitus typ...
<p>Platelet aggregation in patients with coronary artery disease; 307 patients without diabetes (HbA...
The cause of retinopathy in diabetes mellitus is unknown. Among factors suggested to be involved in ...
Aims. To assess differences in blood formed elements aggregation activity in patients with type 1 ...
Patients with diabetes mellitus have an increased risk of thrombosis and accelerated atherogenesis. ...
Vascular complications in the course of type 11 diabetes mellitus are the most important causes of m...
frequently the final event in coronary or cerebral arterial occlusion, is a result of the interplay ...
Objective: The purpose of this study was to assess platelet aggregation (PA) in the diabetic and in ...
This study investigates whether experimental diabetes alters the ease with which platelet aggregatio...
WOS: 000174768500006PubMed ID: 11917198Background In noninsulin-dependent type II diabetic (tIIDM) p...
Contrasting data have been reported so far on the role of reticulated platelets in suboptimal respon...
Hyperglycaemia may attenuate the antiplatelet effect of aspirin and thereby increase the risk of car...
Having previously shown an increase in white blood cell (WBC) aggregation in groups known to have a ...
Patients with diabetes mellitus have an increased prevalence of vascular disease. Pathologic thrombo...
Hyperglycaemia may attenuate the antiplatelet effect of aspirin and thereby increase the risk of car...
Background. Disorders of hemostasis in patients with arterial hypertension and diabetes mellitus typ...